Skip to main content

Table 4 List of differentially methylated sites (DMS), differentially methylated regions (DMRs) and genes content in the four comparisons

From: Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Comparison

DMS

DMR

Genes

WT1 and WT2 versus FXS1

7343

40

32

WT1 and WT2 versus FXS2

33,950

365

300

FXS1 UT versus FXS1 T1 (n = 2)

1706

0

0

FXS2 UT versus FXS2 T1 (n = 2)

528

0

0

Back to article page

Epigenetics & Chromatin

ISSN: 1756-8935